Deshmukh P, Casavant D A, Romanyshyn M, Anderson K
Cardiology Division, Robert Packer Hospital, Sayre, Penn, and Medtronic, Inc, Minneapolis, MN, USA.
Circulation. 2000 Feb 29;101(8):869-77. doi: 10.1161/01.cir.101.8.869.
Direct His-bundle pacing (DHBP) produces synchronous ventricular depolarization and improved cardiac function relative to apical pacing. Although it has been performed transiently in the electrophysiology laboratory and persistently in open-chested canines, permanent DHBP in humans has not been achieved.
A total of 18 patients aged 69+/-10 years who had a history of chronic atrial fibrillation, dilated cardiomyopathy, and normal activation (ie, QRS< or =120 ms) were screened for permanent DHBP using an electrophysiology catheter. In 14 patients, the His bundle could be reliably stimulated. Of these 14, permanent DHBP using a fixed screw-in lead was successful in 12 patients. Radiofrequency atrioventricular node ablation was performed in patients exhibiting a fast ventricular response. All patients received single-chamber rate-responsive pacemakers. Acute pacing thresholds were 2.4+/-1.0 V at a pulse duration of 0.5 ms. Lead complications included exit block requiring reoperative adjustment and gross lead dislodgment. Echocardiographic improvement in heart function was shown by reductions in the left ventricular end-diastolic dimension from 59+/-8 to 52+/-6 mm (P</=0.01) and in the end-systolic dimension from 51+/-10 to 43+/-8 mm (P<0.01), with an accompanying increase in fractional shortening from 14+/-7% to 20+/-10% (P=0.05). The left ventricular ejection fraction improved from 20+/-9% to 31+/-11% (P<0. 01), and the cardiothoracic ratio decreased from 0.61+/-0.06 to 0. 57+/-0.07 (P<0.01). Despite DHBP, 2 patients died at 8 and 36 months. Conclusions-Permanent DHBP is feasible in select patients who have chronic atrial fibrillation and dilated cardiomyopathy. Long-term, DHBP results in a reduction of left ventricular dimensions and improved cardiac function.
与心尖部起搏相比,直接希氏束起搏(DHBP)可产生同步的心室去极化并改善心脏功能。尽管在电生理实验室中已进行过短暂的直接希氏束起搏,在开胸犬中也进行过持续的直接希氏束起搏,但尚未在人类中实现永久性直接希氏束起搏。
共有18例年龄为69±10岁、有慢性房颤、扩张型心肌病病史且激动正常(即QRS≤120毫秒)的患者接受了使用电生理导管进行永久性直接希氏束起搏的筛查。在14例患者中,可以可靠地刺激希氏束。在这14例患者中,12例使用固定螺旋电极成功实现了永久性直接希氏束起搏。对心室反应较快的患者进行了射频房室结消融。所有患者均接受了单腔频率应答起搏器。在脉宽为0.5毫秒时,急性起搏阈值为2.4±1.0伏。电极并发症包括需要再次手术调整的出口阻滞和电极严重移位。超声心动图显示心脏功能改善,左心室舒张末期内径从59±8毫米降至52±6毫米(P≤0.01),收缩末期内径从51±10毫米降至43±8毫米(P<0.01),同时射血分数从14±7%增加至20±10%(P=0.05)。左心室射血分数从20±9%提高到31±11%(P<0.01),心胸比率从0.61±0.06降至0.57±0.07(P<0.01)。尽管进行了直接希氏束起搏,仍有2例患者分别在8个月和36个月时死亡。结论——永久性直接希氏束起搏在患有慢性房颤和扩张型心肌病的特定患者中是可行的。长期来看,直接希氏束起搏可减小左心室尺寸并改善心脏功能。